Skip to main content
. Author manuscript; available in PMC: 2021 Sep 20.
Published in final edited form as: J Neurooncol. 2017 Sep 12;135(1):29–36. doi: 10.1007/s11060-017-2557-y

Table 1.

Summary of the highly confident mutations used for ddPCR fluorescent probes

Probe Sample Gene Chromosome Position Mutation type Number of tools that called the mutation Tumor
Normal
Reference allele reads (%) Mutant allelle reads (%) Reference allele reads (%) Mutant allelle reads (%)
1 Case 1 XKR7 chr20 30585194 Nonsynonymous 4/4 63 (62%) 39 (38%) 59 (97%) 2 (3%)
2 Case 1 GPR112 chrX 135443724 Nonsynonymous 4/4 65 (76%) 20 (24%) 67 (100%) 0 (0%)
3 Case 1 OR5AC2 chr3 97806176 Nonsynonymous 4/4 142 (75%) 48 (25%) 128 (100%) 0 (0%)
4 Case 1 GPR112 chrX 135429739 Nonsynonymous 4/4 60 (67%) 29 (33%) 59 (100%) 0 (0%)
5 Case 1 DDX41 chr5 176943308 Synonymous 4/4 61 (59%) 43 (41%) 65 (100%) 0 (0%)
6 Case 2 FSCB chrl4 44974189 Nonsynonymous 4/4 53 (56%) 42 (44%) 96 (96%) 4 (4%)
7 Case 3 CDH5 chrl6 66426221 Nonsynonymous 4/4 24 (41%) 34 (59%) 46 (100%) 0 (0%)
8 Case 3 PICALM chrll 85692828 Not exonic 4/4 21 (57%) 16 (43%) 44 (100%) 0 (0%)

The gene for probe four (bolded), GPR112, was listed in the COSMIC database (COSM363149)